A study screening for IgLON5 antibodies among a cohort of 32 patients with a clinical diagnosis of PSP found one positive patient, other studies turned out to be negative [12, 19, 24]. The gene discussed is IGLON5; the disease is supranuclear palsy, progressive, 1.